NCT06671301

Brief Summary

This two-arm, pilot, cross-over randomized controlled trial took place at Diabetes Laboratory, First Department of Propaedeutic Internal Medicine, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece the from February 2024 to June of 2024. The study protocol was approved by the Ethics Committee of First Department of Propaedeutic Internal Medicine, Laiko General Hospital(Protocol no 2401/February 27,2024)and was consistent with the Helsinki Declaration for human studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 31, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
Last Updated

November 5, 2024

Status Verified

November 1, 2024

Enrollment Period

4 months

First QC Date

October 31, 2024

Last Update Submit

November 1, 2024

Conditions

Keywords

StressLifestyle medicineTelomeresSense of Coherence

Outcome Measures

Primary Outcomes (2)

  • Telomeres length

    Quantitative PCR (qPCR) to determine relative telomere length

    Before and after the intervention(2 months)

  • Sense of Coherence

    Sense of Coherence was assessed with the Sense of Coherence scale (SOC-13). The scale consists of 13 items rated from 0 to 7. It is considered to have high internal consistency reliability and high validity when compared to other scales measuring the same personality trait.

    Before and after the intervention(2 months)

Secondary Outcomes (11)

  • Perceived Stress Scale-14

    Before and after the intervention(2 months)

  • Pittsburgh Sleep Quality Index

    Before and after the intervention(2 months)

  • Med Diet Score

    Before and after the intervention(2 months)

  • Electrolytic Extracellular Bioimpedance Tomography (TomEEX)

    Before and after the intervention(2 months)

  • Body composition analysis

    Before and after the intervention(2 months)

  • +6 more secondary outcomes

Study Arms (2)

PSAI group

EXPERIMENTAL

Behavioural counselling

Behavioral: PSAI

Control group

OTHER

No intervention used

Other: Usual Care

Interventions

PSAIBEHAVIORAL

Holistic stress management program implementing the pillars of Lifestyle Medicine

PSAI group

Usual care without specific treatment

Control group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically healthy adults
  • Speaking and writing in Greek language

You may not qualify if:

  • Participation in another stress management trial
  • diagnosis of any serious mental disorder
  • short-term or long-term treatment with corticosteroids
  • drug addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Post-graduate course of Stress Science and Health Promotion, NKUA

Athens, 15669, Greece

Location

Related Publications (4)

  • Athanasopoulou S, Simos D, Charalampopoulou M, Tentolouris N, Kokkinos A, Bacopoulou F, Aggelopoulou E, Zigkiri E, Chrousos GP, Darviri C, Gonos ES. Significant improvement of stress and aging biomarkers using a novel stress management program with the cognitive restructuring method "Pythagorean Self-Awareness Intervention" in patients with type 2 diabetes mellitus and healthy adults. Mech Ageing Dev. 2021 Sep;198:111538. doi: 10.1016/j.mad.2021.111538. Epub 2021 Jul 1.

    PMID: 34217756BACKGROUND
  • Zigkiri ES, Nicolaides NC, Bacopoulou F, Simos D, Vlachakis D, Chrousos GP, Darviri C. The Effect of the Pythagorean Self-Awareness Intervention on Psychological, Lifestyle and Cognitive Measures of a Community Sample. J Mol Biochem. 2020;9(1):32-40. Epub 2020 Dec 30.

    PMID: 33520744BACKGROUND
  • Charalampopoulou M, Bacopoulou F, Syrigos KN, Filopoulos E, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial. Breast. 2020 Feb;49:210-218. doi: 10.1016/j.breast.2019.12.012. Epub 2019 Dec 20.

    PMID: 31901782BACKGROUND
  • Simos DS, Kokkinos A, Tentolouris N, Dimosthenopoulos C, Mantzou E, Artemiadis A, Bacopoulou F, Nicolaides NC, Kosta O, Chrousos GP, Darviri C. Pythagorean self-awareness intervention: A novel cognitive stress management technique for body weight control. Eur J Clin Invest. 2019 Oct;49(10):e13164. doi: 10.1111/eci.13164. Epub 2019 Sep 16.

    PMID: 31421060BACKGROUND

Study Officials

  • Nicolaos Tentolouris, Professor

    First Department of Propaedeutic Internal Medicine, Medical School, NKUA, Greece

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 4, 2024

Study Start

February 1, 2024

Primary Completion

June 1, 2024

Study Completion

June 5, 2024

Last Updated

November 5, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Upon request

Locations